| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.63 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |